Place of methotrexate in the treatment of psoriasis in the era of biologic agents
نویسنده
چکیده
Methotrexate (MTX) belongs to a group of drugs known as antimetabolites and is a structural analog of folic acid. It was used for the first time for the treatment of psoriasis over 50 years ago. Nowadays it is used in every type of moderate-to-severe psoriasis, including psoriatic arthritis, and is considered as the most effective disease modifying drug (DMARD). In this paper we review the current state of knowledge as regards mechanisms of action, effectiveness and toxicity of MTX in psoriatic patients as well as we present ways of its administration.
منابع مشابه
Does Short-Term Low-Dose Methotrexate Treatment Affect Homocysteine Blood Level in Patients with Psoriasis?
Background: An elevated homocysteine level is an independent risk factor for cardiovascular disorders. Psoriatic patients have an increased risk of cardiovascular diseases; In addition, hyperhomocysteinemia is a complication of methotrexate treatment. We undertook a study to evaluate the plasma levels of homocysteine, vitamin B12 and folate in patients with psoriasis before and after short-term...
متن کاملCost-Effectiveness Analysis of Psoriasis Treatment Modalities in Malaysia
Background There is limited evidence detailing the cost-effectiveness of psoriasis treatments in the Asian region. Therefore, this study is aimed to evaluate the cost-effectiveness of 3 psoriasis treatments tailored for moderate to severe psoriasis, namely topical and phototherapy (TP), topical and systemic (TS), and topical and biologic (TB) regimens, respectively. Me...
متن کاملComparison of bath PUVA and Acitretin in treatment of Psoriatic patients
Background: Psoriasis treatment is very important regard to mental sequeler and creating morbidity. First line treatment of generalized plaque type psoriasis includes methotrexate, phototherapy and retinoids. Objective: To compare bath-PUVA and acitretin in the treatment of generalized plaque type psoriasis. Patients and Methods: 40 patients with generalized plaque type psoriasis with PAS...
متن کاملCould anti IL12/23 therapy replace anti-TNF biologics?
Biologic therapies improved dramatically the outcome of psoriatic arthritis and moderate to severe chronic plaque psoriasis. Anti-TNF agents were developed approximately one decade ago by rheumatologists and today represent one of the most effective classes of drugs in severe psoriasis resistant to 2 out of 3 "classic" systemic therapies (methotrexate, cyclosporine, and PUVA). Recent studies on...
متن کاملUse of Biologic Agents in Combination with Other Therapies for the Treatment of Psoriasis
Psoriasis is a chronic inflammatory skin disorder, which is associated with a significant negative impact on a patient's quality of life. Traditional therapies for psoriasis are often not able to meet desired treatment goals, and high-dose and/or long-term use is associated with toxicities that can result in end-organ damage. An improved understanding of the involvement of cytokines in the etio...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2012